PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia (NCT05313165)
Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial
🩺 Plain-English Summary (8th-Grade Level)
A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.
Who can join: Review the eligibility criteria below.
Location: University of California, San Diego Health — La Jolla, California
Age range: 18 Years to 95 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (30 Sites)
Showing the first 25 of 30 sites.
- University of California, San Diego Health — La Jolla, California
- Stanford University School of Medicine — Palo Alto, California
- UCSF — San Francisco, California
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center — Torrance, California
- Yale University — New Haven, Connecticut
- The Cardiac and Vascular Institute — Gainesville, Florida
- University of Florida — Gainesville, Florida
- Tallahassee Research Institute — Tallahassee, Florida
- Rush University Medical Center — Chicago, Illinois
- Massachusetts General Hospital — Boston, Massachusetts
- Boston Medical Center — Boston, Massachusetts
- UMass Chan Medical School — Worcester, Massachusetts
- Washington University / Barnes Jewish — St Louis, Missouri
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire
- Vascular Institute of Atlantic Medical Imaging — Pomona, New Jersey
- Holy Name Medical Center — Teaneck, New Jersey
- Presbyterian Healthcare — Albuquerque, New Mexico
- Northwell Health Long Island Jewish Medical Center — Lake Success, New York
- NYU Langone Health — New York, New York
- Mount Sinai — New York, New York
- Cornell University — New York, New York
- Atrium Health — Charlotte, North Carolina
- University Hospitals Cleveland Medical Center — Cleveland, Ohio
- Penn State Health — Hershey, Pennsylvania
- University of Pennsylvania — Philadelphia, Pennsylvania
📞 Contact the Study Coordinator
Phone: (888) 478-7705
Email: etowery@limflow.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Critical Limb Ischemia
- Trial to Assess Chelation Therapy in Critical Limb Ischemia — Miami Beach, Florida
- MOTIV BTK Randomized Controlled Trial — El Centro, California
- Serrantor OCT Study — New York, New York
- FAZA PET/MRI in CLI Patients Pre and Post Revascularization — Toronto, Ontario
- Nutrition in Patient With Critical Limb Ischemia — Boston, Massachusetts
Explore by condition: All Critical Limb Ischemia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.